Skip to main content
Premium Trial:

Request an Annual Quote

NIH Issues Request for SBIR/STTR Applications

NEW YORK (GenomeWeb News) – The National Institutes of Health on Friday issued requests for applications for two trans-NIH funding programs for small businesses focused on bioscience and biomedicine, including the Small Business Innovation Research grants and the Small Business Technology Transfer program.

The STTR grants will give either up to $100,000 (Phase I) for one year or $750,000 (Phase II) for up to two years.

The SBIR grants will provide either up to $100,000 (Phase I) for a period of up to six months or up to $750,000 (Phase II) for a period of no more than two years.

The STTR program is aimed at using federal funds to stimulate "a partnership of ideas and technologies between innovative small business concerns and non-profit institutions," and to assist small businesses and research communities in commercializing innovative technologies, according to NIH.

The SBIR program is focused on several goals, including: stimulating technological innovation in the private sector; strengthening the role of small business in meeting federal R&D needs; increasing commercial applications of federally-supported research; fostering participation by socially and economically disadvantaged and women-owned small business concerns; improving the return on investment from federally-funded research.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.